Investing

MeiraGTx : MGTX

MGTX

Stock Data

$9.41

$0.19 (2.06%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

MeiraGTx Holdings plc is a pioneering force in the field of gene therapy, dedicated to crafting innovative treatments for serious diseases. With a focus on ocular diseases such as inherited retinal diseases and degenerative conditions, as well as neurodegenerative diseases and xerostomia, the company is advancing a diverse portfolio of therapies. Its research spans from early to mid-stage clinical trials, including efforts to combat achromatopsia, X-linked retinitis pigmentosa, and Parkinson’s disease. Founded in 2015 and headquartered in New York, MeiraGTx collaborates with Janssen Pharmaceuticals to push the boundaries of gene therapy for inherited retinal diseases.

All MeiraGTx Articles

1 Article

Joshua Rodriguez | Jul 30, 2024 at 8:49 AM EDT

5 Penny Stocks With 250% Upside in 1 Year According to Wall Street

Penny stocks represent an interesting investment opportunity. These stocks typically represent small companies or companies that are early in the…